Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN1 | Q05586 | 1/20 | 0.39 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.34 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.32 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.32 |
| ▸ | PADI4 | Q9UM07 | 2/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.31 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL163417 | 0.98 | GRIN1 (0.41) | GRIN1GRIN2BEPHX1GRIK1GRIK2 | |
| SCHEMBL3114037 | 0.98 | GRIN1 (0.41) | GRIN1GRIN2BEPHX1GRIK1GRIK2 | |
| SCHEMBL4079497 | 0.98 | GRIN1 (0.41) | GRIN1GRIN2BEPHX1GRIK1GRIK2 | |
| SCHEMBL4743867 | 0.95 | — | — | |
| SCHEMBL730203 | 0.90 | HDAC2 (0.34) | GRIN1GRIN2B | |
| SCHEMBL543403 | 0.90 | — | — | |
| SCHEMBL6360578 | 0.81 | EPHX2 (0.33) | — | |
| SCHEMBL730032 | 0.80 | EPHX1 (0.34) | EPHX1ALOX5CES2CES1 | |
| SCHEMBL30980070 | 0.80 | EPHX1 (0.34) | EPHX1ALOX5CES2CES1 | |
| SCHEMBL3260266 | 0.79 | TSHR (0.38) | EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10202366-B2 | Methods of promoting wound healing using CRM1 inhibitors | Karyopharm Therapeutics Inc. (US) | 2019-02-12 | — | — | US | claimed |
| WO-2014088850-A2 | SHALE SWELLING INHIBITORS | ISP INVESTMENTS INC. (US) | 2014-06-12 | — | — | WO | claimed |
| EP-2414456-A1 | DEGRADABLE POLYMER COMPOSITIONS AND USES THEREOF | Isp Investments Inc. (US) | 2012-02-08 | — | — | EP | claimed |
| EP-2346909-A1 | POLYMERS DERIVED FROM N-VINYL FORMAMIDE, VINYL AMIDES OR ACRYLAMIDES, AND REACTION SOLVENT, AND THE USES THEREOF | Isp Investments Inc. (US) | 2011-07-27 | — | — | EP | claimed |
| WO-2010114761-A1 | DEGRADABLE POLYMER COMPOSITIONS AND USES THEREOF | ISP INVESTMENT INC. (US) | 2010-10-07 | — | — | WO | claimed |
| WO-2010056934-A1 | POLYMERS DERIVED FROM N-VINYL FORMAMIDE, VINYL AMIDES OR ACRYLAMIDES, AND REACTION SOLVENT, AND THE USES THEREOF | ISP INVESTMENTS INC. (US) | 2010-05-20 | — | — | WO | claimed |
| US-20250188201-A1 | CATALYST FOR PHOTOCATALYTIC POLYMERIZATION REACTION, AND APPLICATION THEREOF | BEIJING INSTITUTE OF FASHION TECHNOLOGY (CN) | 2025-06-12 | — | — | US | disclosed |
| CN-116813823-A | Supported catalyst, preparation method thereof and application thereof in photocatalytic polymerization | 北京服装学院 | 2023-09-29 | — | — | CN | disclosed |
| WO-2023169566-A1 | CATALYST FOR PHOTOCATALYTIC POLYMERIZATION REACTION, AND APPLICATION THEREOF | 北京服装学院 | 2023-09-14 | — | — | WO | disclosed |
| US-11492432-B2 | Resin for nanoimprinting, laminate containing resin for nanoimprinting, printed board containing resin for nanoimprinting, and method for producing nanoimprint substrate | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2022-11-08 | — | — | US | disclosed |
| US-20200223125-A1 | RESIN FOR NANOIMPRINTING, LAMINATE CONTAINING RESIN FOR NANOIMPRINTING, PRINTED BOARD CONTAINING RESIN FOR NANOIMPRINTING, AND METHOD FOR PRODUCING NANOIMPRINT SUBSTRATE | JAPAN SCIENCE & TECH AGENCY (JP) | 2020-07-16 | — | — | US | disclosed |
| US-9452977-B2 | Cyclopentylacrylamide derivative | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 2016-09-27 | — | — | US | disclosed |
| CN-105315224-A | Cyclopentylacrylamide derivative | KYORIN SEIYAKU KK | 2016-02-10 | — | — | CN | disclosed |
| US-20150298387-A1 | RESIN FOR NANOIMPRINTING, LAMINATE CONTAINING RESIN FOR NANOIMPRINTING, PRINTED BOARD CONTAINING RESIN FOR NANOIMPRINTING, AND METHOD FOR PRODUCING NANOIMPRINT SUBSTRATE | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2015-10-22 | — | — | US | disclosed |
| US-8946440-B2 | Cyclopentylacrylamide derivative | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 2015-02-03 | — | — | US | disclosed |
| WO-2014088850-A2 | SHALE SWELLING INHIBITORS | ISP INVESTMENTS INC. (US) | 2014-06-12 | — | — | WO | disclosed |
| EP-2542089-A1 | NUCLEAR TRANSPORT MODULATIORS AND USES THEREOF | Karyopharm Therapeutics, Inc. (US) | 2013-01-09 | — | — | EP | disclosed |
| WO-2011109799-A1 | NUCLEAR TRANSPORT MODULATIORS AND USES THEREOF | KARYOPHARM THERAPEUTICS, INC. (US) | 2011-09-09 | — | — | WO | disclosed |
| EP-2346909-A1 | POLYMERS DERIVED FROM N-VINYL FORMAMIDE, VINYL AMIDES OR ACRYLAMIDES, AND REACTION SOLVENT, AND THE USES THEREOF | Isp Investments Inc. (US) | 2011-07-27 | — | — | EP | disclosed |
| WO-2010056934-A1 | POLYMERS DERIVED FROM N-VINYL FORMAMIDE, VINYL AMIDES OR ACRYLAMIDES, AND REACTION SOLVENT, AND THE USES THEREOF | ISP INVESTMENTS INC. (US) | 2010-05-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10202366-B2 | Methods of promoting wound healing using CRM1 inhibitors | XPO1, XPA, ERCC2 | GRIN1 1347/4885GRIN2B 3441/4885EPHX1 2280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.